Discovering New Therapeutic Uses for Existing Molecules (New Therapeutic Uses)

Published by NCATS

The New Therapeutic Uses program aims to improve the process of developing new treatments and cures for disease by finding new uses for assets that already have cleared several key steps along the development path (also known as Drug Repurposing).

View this resource Bookmark this resource

the Biomedical Data Translator

Published by NCATS

Database NCATS

NCATS launched the Biomedical Data Translator (Translator) program to accelerate biomedical translation for the research community. Through this program, NCATS will integrate multiple types of existing data sources and reveal potential relationships across the spectrum of data types.

View this resource Bookmark this resource

Toxicology in the 21st Century (Tox21)

Published by NCATS

Toxicology Test Tool Database

The Tox21 initiative is designed to improve toxicity testing methods and enable faster, more efficient evaluation of chemicals’ effects on human health.

View this resource Bookmark this resource

3-D Tissue Bioprinting program

Published by NCATS

3-D Tissue Model Organoid

The goal of the NCATS 3-D Tissue Bioprinting program is to advance the process of discovery and development of new medicines by developing new assay models that better predict the effects of drugs in humans. 3-D Tissue Models that mimic characteristics of live human tissues are produced on microplates to test effectiveness and toxicity of Small Molecules or other therapeutic.

View this resource Bookmark this resource

Stem Cell Translation Laboratory (SCTL)

Published by NCATS

Stem Cell Patient-derived Induced Pluripotent Stem Cell (iPSC)

NCATS is working to advance translational methods in stem cell research. Induced pluripotent stem cells are particularly useful because scientists can transform them into many different cell types to use for research or therapies.

View this resource Bookmark this resource

Platform Vector Gene Therapy (PaVe-GT)

Published by NCATS

NCATS Gene Therapy Gene Delivery System

This NCATS-led pilot project will test whether it is possible to increase the efficiency of Gene Therapy clinical trial startup by using the same Gene Delivery System and manufacturing methods for multiple gene therapies.

View this resource Bookmark this resource

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience. See our Cookie Policy

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
Bookmark Cookie	12 months	This cookie saves your bookmarked resources to your local browser for future use.
Cookie Policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Analytics

IMT Feedback

Did the IMT help you in finding the resource you needed?